Evidence map›Paper›PMID 41938355›Full record

ArticleaBIOTECH2026

Enhancing the efficiency of nuclease-based prime editing in rice with the Tf1 reverse transcriptase.

Guigen Ma, Hao Xu, Sujie Zhang, Xueqi Li, Jiaqiang Liu, Jiayue Xie, Fang Yan, Huanbin Zhou

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in aBIOTECH, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Genome Editing Approaches in Flax (International journal of molecular sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guigen MaMinistry of Agriculture and Rural Affairs Key Laboratory of Gene Editing Technologies (Hainan), National Nanfan Research Institute, Chinese Academy of Agricultural Sciences, Sanya, 572024, China.
Hao XuMinistry of Agriculture and Rural Affairs Key Laboratory of Gene Editing Technologies (Hainan), National Nanfan Research Institute, Chinese Academy of Agricultural Sciences, Sanya, 572024, China.
Sujie ZhangState Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, 100193, China.
Xueqi LiMinistry of Agriculture and Rural Affairs Key Laboratory of Gene Editing Technologies (Hainan), National Nanfan Research Institute, Chinese Academy of Agricultural Sciences, Sanya, 572024, China.
Jiaqiang LiuMinistry of Agriculture and Rural Affairs Key Laboratory of Gene Editing Technologies (Hainan), National Nanfan Research Institute, Chinese Academy of Agricultural Sciences, Sanya, 572024, China.
Jiayue XieMinistry of Agriculture and Rural Affairs Key Laboratory of Gene Editing Technologies (Hainan), National Nanfan Research Institute, Chinese Academy of Agricultural Sciences, Sanya, 572024, China.
Fang YanMinistry of Agriculture and Rural Affairs Key Laboratory of Gene Editing Technologies (Hainan), National Nanfan Research Institute, Chinese Academy of Agricultural Sciences, Sanya, 572024, China.
Huanbin ZhouMinistry of Agriculture and Rural Affairs Key Laboratory of Gene Editing Technologies (Hainan), National Nanfan Research Institute, Chinese Academy of Agricultural Sciences, Sanya, 572024, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of efficient and precise genome-editing tools is crucial for advancing functional genomics and improving crops. Our previously established nuclease-mediated prime editing (NM-PE) system, which combines the

Indexed as

CRISPR/CasEpitope taggingPrime editingRiceTf1 reverse transcriptase

Identifiers

PMID41938355
PMCPMC12973387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.